HighVista Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,500
Closed -$487K 140
2019
Q2
$487K Buy
+3,500
New +$484K 0.25% 72
2018
Q1
Sell
-2,700
Closed -$377K 202
2017
Q4
$377K Sell
2,700
-1,000
-27% -$139K 0.11% 144
2017
Q3
$481K Sell
3,700
-500
-12% -$66.3K 0.11% 140
2017
Q2
$556K Sell
4,200
-1,400
-25% -$179K 0.13% 118
2017
Q1
$697K Sell
5,600
-1,600
-22% -$191K 0.16% 131
2016
Q4
$830K Buy
+7,200
New +$832K 0.16% 143
2016
Q1
Sell
-14,787
Closed -$1.52M 196
2015
Q4
$1.52M Buy
+14,787
New +$1.49M 0.28% 84
2015
Q2
Sell
-2,100
Closed -$211K 172
2015
Q1
$211K Sell
2,100
-549
-21% -$55.8K 0.03% 170
2014
Q4
$277K Buy
2,649
+478
+22% +$50.4K 0.04% 135
2014
Q3
$231K Buy
+2,171
New +$225K 0.03% 143
2014
Q2
Sell
-2,555
Closed -$257K 162
2014
Q1
$257K Buy
+2,555
New +$237K 0.03% 127

Other funds holding JNJ

HighVista Strategies's JNJ Position: Q3 2019 in Review

HighVista Strategies sold out of Johnson & Johnson (JNJ) in Q3 2019, closing a stake of 3,500 shares — an estimated $487K sold.

HighVista Strategies first reported a position in JNJ in Q1 2014 and held it in 11 quarters. The position peaked at $1.52M in Q4 2015. 2,724 funds tracked by Wall St. Rank hold JNJ as of Q3 2019.

  • HighVista Strategies reported no remaining Johnson & Johnson position as of Q3 2019 after selling out during the quarter.
  • HighVista Strategies sold 3,500 Johnson & Johnson shares in Q3 2019, an estimated $487K.
  • HighVista Strategies first reported a position in Johnson & Johnson in Q1 2014 and held it in 11 quarters.
  • HighVista Strategies's Johnson & Johnson position peaked at $1.52M in Q4 2015.
  • 2,724 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2019.

Based on HighVista Strategies's 13F filing for Q3 2019, filed 14 Nov 2019.